Drug Shows Hope for Advanced Skin Cancer

Both can significantly increase survival for those with metastatic melanoma

(NEWSER) - Two new drugs offer new hope to patients with metastatic melanoma, the typically lethal advanced form of skin cancer. The trial of PLX4032, or vemurafenib, was so successful that the study was halted after three months so that all patients could receive the new drug, the Los Angeles Times reports. It is the first chemotherapy to target a specific mutation that occurs in 47% of melanoma patients. The study found it helped 48% of those patients, compared to just 5.5% who were taking the drug dacarbazine, the conventional treatment. More»

Breast cancer, ovarian cancer, melanoma yield to new approaches

(NEWSER) - New treatments for cancer—breast, ovarian, and skin—raised hopes at this weekend's meeting of the American Society of Clinical Oncology in Chicago. The findings aren't enough for Robert Langreth of Forbes , who sees "serious questions about whether big drug companies may be rushing too fast." Judge for yourself.

• A single dose of radiation administered at the site of tumor removal deterred recurrence of breast cancer as well as the standard grueling course of radiation on the entire breast, the Chicago Tribune reports.

Offers hope in fighting deadly melanoma

(NEWSER) - A new vaccine being tested in the UK may offer hope to patients suffering from the deadliest form of skin cancer. The drug, which attacks tumor cells and boosts the body's response to skin cancer without affecting healthy cells, appears to cure advanced melanoma in some patients. In a study of 50 melanoma patients, 16% who'd been given no more than nine months to live made full recoveries with the vaccine; another 28% saw their tumors shrink to half size. More»

Research shows dropoff of up to 15%

(NEWSER) - Aspirin and other similar painkillers may ward off skin cancer, according to new research. About 20 years of skin cancer data in Denmark show that people who had taken NSAIDs—nonsteroidal anti-inflammatory painkillers—were 15% less likely to develop squamous cell carcinoma and 13% less likely to have malignant melanoma, reports the Los Angeles Times . More»

Researchers blame tanning beds

(NEWSER) - Researchers expected a rise in skin cancer among young women—but they didn't expect this: Between 1970 and 2009, melanoma became eight times more common among women 18 to 39 and four times higher among men in that age group, Time reports. "There is currently a melanoma epidemic in the US, particularly in young women and middle-aged men," notes a Mayo Clinic dermatologist and researcher involved in the study. The increase among women is likely tied to tanning salons, the experts say. More»